Publicaciones en colaboración con investigadores/as de St Bartholomew's Hospital (10)

2023

  1. Long-term safety of spinal cord stimulation systems in a prospective, global registry of patients with chronic pain

    Pain Management, Vol. 13, Núm. 2, pp. 115-127

2021

  1. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

2016

  1. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study

    Heart Rhythm, Vol. 13, Núm. 3, pp. 669-682

2015

  1. T-Wave Oversensing in Patients with Brugada Syndrome: True Bipolar Versus Integrated Bipolar Implantable Cardioverter Defibrillator Leads

    Circulation: Arrhythmia and Electrophysiology, Vol. 8, Núm. 4, pp. 792-798

2009

  1. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: Impact of a dose-modification guideline

    British Journal of Haematology, Vol. 144, Núm. 6, pp. 895-903

2008

  1. Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma

    British Journal of Haematology, Vol. 143, Núm. 2, pp. 222-229

2007

  1. Extended follow-up of a phase 3 trial in relapsed multiple myeloma: Final time-to-event results of the APEX trial

    Blood, Vol. 110, Núm. 10, pp. 3557-3560

  2. Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma

    British Journal of Haematology, Vol. 137, Núm. 5, pp. 429-435

2006

  1. A practical update on the use of bortezomib in the management of multiple myeloma

    Oncologist, Vol. 11, Núm. 1, pp. 51-61

2005

  1. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    New England Journal of Medicine, Vol. 352, Núm. 24, pp. 2487-2498